Literature DB >> 1979712

Multiple endocrine neoplasia: how many syndromes?

R N Schimke1.   

Abstract

The phrase multiple endocrine neoplasia (MEN) generally denotes an association of tumors so specific as to constitute a syndrome. Three well-recognized such syndromes exist. All are autosomal dominant traits and all have been tentatively mapped to specific chromosomes. Other purported endocrine tumor syndromes have been suggested either as new entities or as subtypes of the existing MEN syndromes. The evidence in favor of these contentions is examined critically. Only one "new" association, that of pheochromocytomas and islet cell tumors, seems reasonable, and even in this setting, some relatives have had manifestations of von Hippel-Lindau syndrome. There is no compelling reason why such conditions as von Hippel-Lindau syndrome, peripheral neurofibromatosis, McCune-Albright syndrome, and others should be reclassified as MEN syndromes, although awareness of their collective endocrine abnormalities is clinically important.

Entities:  

Mesh:

Year:  1990        PMID: 1979712     DOI: 10.1002/ajmg.1320370317

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  The finding of a somaticdeletion in RET exon 15 clarified the sporadic nature of amedullary thyroid carcinoma suspected to be familial.

Authors:  J Oriola; I Halperin; F Rivera-Fillat; H Donis-Keller
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 2.  Primary cardiac pheochromocytoma with multiple endocrine neoplasia.

Authors:  Chaoji Zhang; Guotao Ma; Xingrong Liu; Heng Zhang; Haibo Deng; Justin Nowell; Qi Miao
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-26       Impact factor: 4.553

3.  Genetics of hypertension: the pheochromocytoma model.

Authors:  H P Neumann
Journal:  Clin Investig       Date:  1994-09

4.  Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations

Authors:  Begümhan Demir Gündoğan; Fatih Sağcan; Sevcan Tuğ Bozdoğan; Yüksel Balcı; Ferah Tuncel Daloğlu; Elvan Çağlar Çıtak
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-07-23

5.  Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

Authors:  C Eng; P A Crossey; L M Mulligan; C S Healey; C Houghton; A Prowse; S L Chew; P L Dahia; J L O'Riordan; S P Toledo
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

Review 6.  Coexistence of a pituitary macroadenoma and pheochromocytoma--a case report and review of the literature.

Authors:  Suzanne M Breckenridge; Amir H Hamrahian; Charles Faiman; John Suh; Richard Prayson; Marc Mayberg
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 7.  Multiple endocrine neoplasia type 1 (MEN 1) revisited.

Authors:  B Padberg; S Schröder; C Capella; A Frilling; G Klöppel; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma.

Authors:  Jonathan E Heinlen; David D Buethe; Daniel J Culkin; Gennady Slobodov
Journal:  ISRN Oncol       Date:  2011-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.